On September 5, 2022 (the "Petition Date"), Clarus Therapeutics Holdings, Inc. and Clarus Therapeutics, Inc. (together, the "Debtors") filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code. The Debtor's bankruptcy cases are jointly administered under Case No. 22-10845 before the Honorable Mary F. Walrath in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").

 

Additional information about the bankruptcy cases may be obtained by calling the case information line at 855.432.4327 (toll-free) or 949.242.0794 (international). You may also submit an inquiry via email by clicking HERE.

Debtor

Case No. Debtor Name
22-10845 Clarus Therapeutics Holdings, Inc.
22-10844 Clarus Therapeutics, Inc.

Dates

(Cancelled) Omni Hearing November 06, 2025 (03:00 PM ET)

(Cancelled) Omni Hearing December 09, 2025 (10:30 AM ET)

Pre-Trial Conference March 26, 2026 (11:30 AM ET)

Meeting of Creditors

Pursuant to section 341 of the Bankruptcy Code, the Meeting of Creditors was held telephonically on October 12, 2022 at 4:00 p.m. ET.

Dial-In: (866) 621-1355
Access Code: 7178157#

Professionals

Debtors' Counsel GOODWIN PROCTER LLP
POTTER ANDERSON & CORROON LLP

Court Information

United States Bankruptcy Court
District of Delaware
824 Market Street North
3rd Floor
Wilmington, DE 19801
302.252.2900